Caption Management, LLC Horizon Therapeutics Public LTD CO Transaction History

Caption Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$58.92 - $84.67 $2 Million - $2.87 Million	33,880 Added 123.2%	61,380 $3.8 Million
Q2 2022 Aug 15, 2022	BUY	$79.4 - $116.36 $198,500 - $290,900	2,500 Added 10.0%	27,500 $2.19 Million
Q1 2022 May 13, 2022	SELL	$86.42 - $109.81 $803,706 - $1.02 Million	-9,300 Reduced 27.11%	25,000 $2.63 Million
Q4 2021 Feb 11, 2022	SELL	$98.56 - $119.91 $5.19 Million - $6.32 Million	-52,700 Reduced 60.57%	34,300 $3.7 Million
Q3 2021 Nov 12, 2021	BUY	$91.91 - $110.37 $5.79 Million - $6.95 Million	63,000 Added 262.5%	87,000 $9.53 Million
Q2 2021 Aug 16, 2021	SELL	$86.24 - $95.92 $9.24 Million - $10.3 Million	-107,086 Reduced 81.69%	24,000 $2.25 Million
Q1 2021 May 17, 2021	BUY	$71.83 - $95.48 $9.42 Million - $12.5 Million	131,086 New	131,086 $12.1 Million
Q1 2020 May 15, 2020	SELL	$24.87 - $38.56 $940,086 - $1.46 Million	-37,800 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$25.43 - $36.67 $859,534 - $1.24 Million	33,800 Added 845.0%	37,800 $1.37 Million
Q3 2019 Nov 14, 2019	BUY	$23.0 - $27.97 $92,000 - $111,880	4,000 New	4,000 $109,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.